兰尼单抗

兰尼单抗（英语：Ranibizumab，也译为雷珠单抗，商品名Lucentis）是一种单克隆抗体片段（FAB），其与贝伐单抗（bevacizumab）是从相同亲本鼠抗体获得。它比母体分子小得多，能更紧密的结合到血管内皮生长因子-A(VEGF-A)。它是一种血管生成抑制剂(angiogenesis inhibitor)，已被批准用于治疗的“湿”型老年黄斑变性。

单词	Ranibizumab
释义	Ranibizumab 中文百科兰尼单抗兰尼单抗（英语：Ranibizumab，也译为雷珠单抗，商品名Lucentis）是一种单克隆抗体片段（FAB），其与贝伐单抗（bevacizumab）是从相同亲本鼠抗体获得。它比母体分子小得多，能更紧密的结合到血管内皮生长因子-A(VEGF-A)。它是一种血管生成抑制剂(angiogenesis inhibitor)，已被批准用于治疗的“湿”型老年黄斑变性。英语百科 Ranibizumab 兰尼单抗 Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.
随便看	conference on financial and economic work Conference on International Container Traffic conference on international economic co operation conference on labor and employment work conference on labour and employment work Conference on Laser Engineering and Application conference on Law of Sea conference on law of the sea conference on methodology conference on production Conference On Security and Cooperation In Europe conference on specialized trades conference on the human environment Conference on the Law of the Sea conference overview Conference papers conference papers index Conference pear Conference phone Conference proceedings conference rate conference rates conference regular member conference repeater Conference report

Ranibizumab

兰尼单抗

Ranibizumab 兰尼单抗